This phenomenon of reduced FGF21 action in obesity has been attributed to an abnormal reduction in the expression of the FGF21 co-receptor, β-Klotho, in white adipose tissue, commonly observed in rodent models of obesity and in obese individuals (30). This evidence concerns the gene FGF21 and obesity disorder.